Vera Therapeutics VERA Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $259.99M+20.8% | $215.26M+13.7% | $189.29M+9.3% | $173.13M+20.0% | $144.25M+14.3% | ||
| $123.42M+23.2% | $100.22M+23.9% | $80.89M+28.6% | $62.92M+28.4% | $49M+19.5% | ||
| $383.41M+21.5% | $315.47M+16.8% | $270.18M+14.5% | $236.05M+22.1% | $193.25M+15.6% | ||
| -$383.41M-21.5% | -$315.47M-16.8% | -$270.18M-14.5% | -$236.05M-22.1% | -$193.25M-15.6% | ||
| $7.56M+0.4% | $7.53M+0.4% | $7.5M+0.3% | $7.47M-0.5% | $7.51M-1.5% | ||
| $14.46M-8.8% | $15.86M-13.0% | $18.24M+2.6% | $17.77M-0.1% | $17.79M+18.4% | ||
| —— | -$299.61M-14.0% | -$262.75M-16.3% | -$225.88M-19.5% | -$189.01M-24.2% | ||
| -$368.95M-23.1% | -$299.62M-18.9% | -$251.94M-15.4% | -$218.28M-24.4% | -$175.46M-15.3% | ||
| -$5.54-18.9% | -$4.66-16.8% | -$3.99-11.5% | -$3.58-19.3% | -$3.00-9.1% | ||
| -$382.89M-21.5% | -$315.01M-16.8% | -$269.79M-14.4% | -$235.77M-22.1% | -$193.07M-15.6% | ||
| -$383.41M-21.5% | -$315.47M-16.8% | -$270.18M-14.5% | -$236.05M-22.1% | -$193.25M-15.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Vera Therapeutics's income statement data come from?
- Every line is extracted from Vera Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.